Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients

Byung Ho Kong, Ju Hyung Moon, yongmin Huh, Jin Kyoung Shim, Ji Hyun Lee, Eui Hyun Kim, Jong Hee Chang, Dong Seok Kim, Yong Kil Hong, Sun Ho Kim, Su Jae Lee, Seok-Gu Kang

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Cancer stem cells (CSCs) have been reported to be critical in the initiation, maintenance, and progression of cancers. The expression of stem cell markers, such as podoplanin (PDPN), CD133, and nestin, may have been correlated with malignant progression. However, the effects of CSCs and stem cell markers on clinical outcomes in cancer patients remain unclear. In this study, we assessed the prognostic roles of glioma CSCs (gCSCs) isolation and stem cell markers in patients with primary glioblastoma (pGBM). A cohort of 39 patients with pGBM was separated into two groups, those positive or negative for gCSCs, and the correlation between gCSC and patient survival was evaluated. We observed significantly different cumulative survival (P = 0.045) when comparing patients positive for gCSCs patients and negative for gCSC. Among the patients positive for gCSCs, we observed no significant differences in survival between those whose gCSCs were each positive or negative for PDPN, CD133, or nestin. This study strongly supports the prognostic value of gCSCs isolation on the survival of patients with pGBM.

Original languageEnglish
Article number838950
JournalStem Cells International
Volume2014
DOIs
Publication statusPublished - 2014 Dec 11

Fingerprint

Neoplastic Stem Cells
Cell Separation
Glioblastoma
Glioma
Survival
Nestin
Stem Cells
Neoplasms
Biomarkers
Maintenance

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cell Biology

Cite this

Kong, Byung Ho ; Moon, Ju Hyung ; Huh, yongmin ; Shim, Jin Kyoung ; Lee, Ji Hyun ; Kim, Eui Hyun ; Chang, Jong Hee ; Kim, Dong Seok ; Hong, Yong Kil ; Kim, Sun Ho ; Lee, Su Jae ; Kang, Seok-Gu. / Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients. In: Stem Cells International. 2014 ; Vol. 2014.
@article{d33168b03fef44c4b53e52e01c40d51a,
title = "Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients",
abstract = "Cancer stem cells (CSCs) have been reported to be critical in the initiation, maintenance, and progression of cancers. The expression of stem cell markers, such as podoplanin (PDPN), CD133, and nestin, may have been correlated with malignant progression. However, the effects of CSCs and stem cell markers on clinical outcomes in cancer patients remain unclear. In this study, we assessed the prognostic roles of glioma CSCs (gCSCs) isolation and stem cell markers in patients with primary glioblastoma (pGBM). A cohort of 39 patients with pGBM was separated into two groups, those positive or negative for gCSCs, and the correlation between gCSC and patient survival was evaluated. We observed significantly different cumulative survival (P = 0.045) when comparing patients positive for gCSCs patients and negative for gCSC. Among the patients positive for gCSCs, we observed no significant differences in survival between those whose gCSCs were each positive or negative for PDPN, CD133, or nestin. This study strongly supports the prognostic value of gCSCs isolation on the survival of patients with pGBM.",
author = "Kong, {Byung Ho} and Moon, {Ju Hyung} and yongmin Huh and Shim, {Jin Kyoung} and Lee, {Ji Hyun} and Kim, {Eui Hyun} and Chang, {Jong Hee} and Kim, {Dong Seok} and Hong, {Yong Kil} and Kim, {Sun Ho} and Lee, {Su Jae} and Seok-Gu Kang",
year = "2014",
month = "12",
day = "11",
doi = "10.1155/2014/838950",
language = "English",
volume = "2014",
journal = "Stem Cells International",
issn = "1687-9678",
publisher = "Hindawi Publishing Corporation",

}

Kong, BH, Moon, JH, Huh, Y, Shim, JK, Lee, JH, Kim, EH, Chang, JH, Kim, DS, Hong, YK, Kim, SH, Lee, SJ & Kang, S-G 2014, 'Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients', Stem Cells International, vol. 2014, 838950. https://doi.org/10.1155/2014/838950

Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients. / Kong, Byung Ho; Moon, Ju Hyung; Huh, yongmin; Shim, Jin Kyoung; Lee, Ji Hyun; Kim, Eui Hyun; Chang, Jong Hee; Kim, Dong Seok; Hong, Yong Kil; Kim, Sun Ho; Lee, Su Jae; Kang, Seok-Gu.

In: Stem Cells International, Vol. 2014, 838950, 11.12.2014.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients

AU - Kong, Byung Ho

AU - Moon, Ju Hyung

AU - Huh, yongmin

AU - Shim, Jin Kyoung

AU - Lee, Ji Hyun

AU - Kim, Eui Hyun

AU - Chang, Jong Hee

AU - Kim, Dong Seok

AU - Hong, Yong Kil

AU - Kim, Sun Ho

AU - Lee, Su Jae

AU - Kang, Seok-Gu

PY - 2014/12/11

Y1 - 2014/12/11

N2 - Cancer stem cells (CSCs) have been reported to be critical in the initiation, maintenance, and progression of cancers. The expression of stem cell markers, such as podoplanin (PDPN), CD133, and nestin, may have been correlated with malignant progression. However, the effects of CSCs and stem cell markers on clinical outcomes in cancer patients remain unclear. In this study, we assessed the prognostic roles of glioma CSCs (gCSCs) isolation and stem cell markers in patients with primary glioblastoma (pGBM). A cohort of 39 patients with pGBM was separated into two groups, those positive or negative for gCSCs, and the correlation between gCSC and patient survival was evaluated. We observed significantly different cumulative survival (P = 0.045) when comparing patients positive for gCSCs patients and negative for gCSC. Among the patients positive for gCSCs, we observed no significant differences in survival between those whose gCSCs were each positive or negative for PDPN, CD133, or nestin. This study strongly supports the prognostic value of gCSCs isolation on the survival of patients with pGBM.

AB - Cancer stem cells (CSCs) have been reported to be critical in the initiation, maintenance, and progression of cancers. The expression of stem cell markers, such as podoplanin (PDPN), CD133, and nestin, may have been correlated with malignant progression. However, the effects of CSCs and stem cell markers on clinical outcomes in cancer patients remain unclear. In this study, we assessed the prognostic roles of glioma CSCs (gCSCs) isolation and stem cell markers in patients with primary glioblastoma (pGBM). A cohort of 39 patients with pGBM was separated into two groups, those positive or negative for gCSCs, and the correlation between gCSC and patient survival was evaluated. We observed significantly different cumulative survival (P = 0.045) when comparing patients positive for gCSCs patients and negative for gCSC. Among the patients positive for gCSCs, we observed no significant differences in survival between those whose gCSCs were each positive or negative for PDPN, CD133, or nestin. This study strongly supports the prognostic value of gCSCs isolation on the survival of patients with pGBM.

UR - http://www.scopus.com/inward/record.url?scp=84919799052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919799052&partnerID=8YFLogxK

U2 - 10.1155/2014/838950

DO - 10.1155/2014/838950

M3 - Article

AN - SCOPUS:84919799052

VL - 2014

JO - Stem Cells International

JF - Stem Cells International

SN - 1687-9678

M1 - 838950

ER -